Advanced Therapies UK 2027
Advanced Therapies UK is Terrapinn's commercial cell and gene therapy conference and exhibition in London. It brings together developers, manufacturers, investors and service providers across the advanced therapy value chain.
Tuesday to Wednesday · 2 days
Organizer
Published by the organizer
Every year
How often it's held
Checked October 20, 2026
Reported attendance
3,000+
attendees · year not stated
Reported exhibitors
Not published
About Advanced Therapies UK 2027
Advanced Therapies UK is Terrapinn's commercial cell and gene therapy conference and exhibition in London. Terrapinn also calls it the Advanced Therapies Congress and describes it as Europe’s largest commercial cell and gene therapy event. It's built for leaders of ATMP developers, their suppliers, investors, clinicians, payers and regulators. The next edition runs 9 to 10 March 2027 at ExCeL London. Terrapinn's home page cites 3,000+ attendees, 300+ speakers and 75+ start-ups, without giving a year.
300+
Speakers
75+
Biotech start-ups
10
Conference tracks
20.1%
C-level attendees
40%
Attendees from the UK
What happens at Advanced Therapies UK
Advanced Therapies UK combines a two-day conference with an exhibition and start-up zone. The 2027 agenda runs keynotes plus ten numbered tracks across 9 and 10 March. Tracks include gene therapy, cell therapy, gene modified cell therapy, viral vector manufacturing and supply chain and logistics.
Other tracks cover immunotherapy, gene editing, regulation, evidence, pricing and access, and a start-ups showcase. The first day also holds 13 numbered roundtables over lunch, on topics from AAV versus lentiviral vectors to NHS workforce readiness.
A Clinicians Hub points healthcare professionals to clinical sessions, CPD-accredited learning and the poster session. Registered attendees can submit a poster free of charge by 14 February 2027. The home page promises 12+ hours of built-in 1-2-1 networking, which Terrapinn runs through its event app.
Who attends Advanced Therapies UK
The audience is senior people from cell and gene therapy developers, their suppliers and the health systems that use these products. Terrapinn's 2027 sales catalog lists CEOs, CSOs, VPs of pharma and biotech, investors, payers, HTAs, clinicians, regulators and academics.
- Other26.9%
- C-Level20.1%
- Director14%
- Business Development/ Marketing13.5%
- HoD/Lead10.5%
- Manager6.8%
- VP4.7%
- Founder/President/Partner3.6%
Seniority of attendees chart in Terrapinn's 2027 sales catalog. The catalog doesn't give the year of the data.terrapinn-cdn.com ↗
- UK40%
- Europe30%
- USA25%
- Asia & Oceania5%
Geographic breakdown in Terrapinn's 2027 sales catalog. The catalog doesn't give the year of the data.terrapinn-cdn.com ↗
The same catalog gives a seniority split without saying which year it covers. C-level attendees make up 20.1%, directors 14% and heads of department or leads 10.5%. Business development and marketing staff make up 13.5%, and 26.9% fall under other.
By region, the catalog shows 40% from the UK, 30% from Europe, 25% from the USA and 5% from Asia and Oceania. Headline audience figures vary across Terrapinn's pages. The home page says 3,000+ attendees, while the Our story page lists 2500+ attendees among its 2026 plans. Drug Discovery News reported more than 3,300 global executives at the 2026 congress.
Attendance and exhibitors by year
As the organizer reports them. What's counted varies between events, so compare with care.
| Edition | Attendance |
|---|---|
| Not stated | 3,000+attendeesHeadline figure on Terrapinn's 2027 event home page. The page doesn't give the year.terrapinn.com ↗ |
Companies exhibiting and speaking at Advanced Therapies UK 2027
The official 2027 sponsor and exhibitor list named 54 companies when we checked on 20 October 2026. Large suppliers sit alongside specialist CDMOs, cold chain logistics firms and young tool makers. Speakers on the 2027 agenda come from developers such as Orchard Therapeutics, Autolus, MeiraGTx and Legend Biotech, and from Roche and AstraZeneca.
Sponsors (18)Asimov, Lonza, Sartorius Lab Instruments GmbH & Co. KG and 15 more
- Asimov · 2027Platinum Sponsor on the 2027 sponsor and exhibitor list
- Lonza · 2027Platinum Sponsor on the 2027 sponsor and exhibitor list
- Sartorius Lab Instruments GmbH & Co. KG · 2027Platinum Sponsor on the 2027 sponsor and exhibitor list
- AGC Biologics · 2027Gold Sponsor on the 2027 sponsor and exhibitor list
- Miltenyi Biotec · 2027Silver Sponsor on the 2027 sponsor and exhibitor list
- Bio-Techne · 2027Silver Sponsor on the 2027 sponsor and exhibitor list
- Cencora/ World Courier · 2027Silver Sponsor on the 2027 sponsor and exhibitor list
- Cytiva · 2027Silver Sponsor on the 2027 sponsor and exhibitor list
- SK pharmteco · 2027Silver Sponsor on the 2027 sponsor and exhibitor list
- Cryoport Systems · 2027Silver Sponsor on the 2027 sponsor and exhibitor list
- Fujifilm Biotechnologies · 2027Silver Sponsor on the 2027 sponsor and exhibitor list
- Master Control Solutions Inc · 2027Silver Sponsor on the 2027 sponsor and exhibitor list
- Biocair International Ltd · 2027Silver Sponsor on the 2027 sponsor and exhibitor list
- Catapult · 2027Silver Sponsor on the 2027 sponsor and exhibitor list
- Aldevron · 2027Associate Sponsor on the 2027 sponsor and exhibitor list
- Andelyn Biosciences · 2027Associate Sponsor on the 2027 sponsor and exhibitor list
- BioLife Solutions · 2027Associate Sponsor on the 2027 sponsor and exhibitor list
- RoslinCT · 2027Associate Sponsor on the 2027 sponsor and exhibitor list
Exhibitors (37)ChemoMetec Inc., Aseptic Technologies, Bramble Bio and 34 more
- ChemoMetec Inc. · 2027Listed as a 2027 exhibitor
- Aseptic Technologies · 2027Listed as a 2027 exhibitor
- Bramble Bio · 2027Listed as a 2027 exhibitor
- c-lecta gmbh · 2027Listed as a 2027 exhibitor
- 3P BIOPHARMACEUTICALS S.L.U. · 2027CDMO for biotech and pharma, listed as 3PBIOVIAN
- Danaher Corporation · 2027Listed as a 2027 exhibitor
- Advent Bioservices · 2027Listed as a 2027 exhibitor
- Anthony Nolan · 2027Listed as a 2027 exhibitor
- ArcticZymes · 2027Listed as a 2027 exhibitor
- Arvato Supply Chain Solutions · 2027Listed as a 2027 exhibitor
- Catalonia Trade & Investment · 2027Listed as a 2027 exhibitor
- Cellex GmbH · 2027Listed as a 2027 exhibitor
- CPC Colder Products Company · 2027Listed as a 2027 exhibitor
- Cytek · 2027Listed as a 2027 exhibitor
- eXmoor Pharma · 2027Listed as a 2027 exhibitor
- Fresenius Kabi · 2027Listed as a 2027 exhibitor
- Green Elephant Biotech · 2027Adherent cell expansion systems for iPSC, MSC and macrophage manufacturing
- Harro Hoefliger · 2027Listed as a 2027 exhibitor
- Histologix Ltd · 2027Listed as a 2027 exhibitor
- Intertek · 2027Listed as a 2027 exhibitor
- Kuhner Shaker Ltd · 2027Listed as a 2027 exhibitor
- New England Biolabs Inc · 2027Listed as a 2027 exhibitor
- Octapharma · 2027GMP grade plasma derived proteins and serum media additives
- OriGen Biomedical · 2027Cryopreservation and cell culture products
- OXB · 2027Listed as a 2027 exhibitor
- Porton · 2027Listed as a 2027 exhibitor
- QuickSTAT A Kuehne + Nagel Company · 2027Listed as a 2027 exhibitor
- RareGenix/Minaret Consulting Limited · 2027Listed as a 2027 exhibitor
- Repligen · 2027Listed as a 2027 exhibitor
- Roche Diagnostics Deutschland GmbH · 2027Listed as a 2027 exhibitor
- Rose BioSolutions · 2027Listed as a 2027 exhibitor
- Scinus Cell Expansion · 2027Listed as a 2027 exhibitor
- SGS Vitrology · 2027Listed as a 2027 exhibitor
- time matters · 2027Listed as a 2027 exhibitor
- unveil · 2027Label-free optical characterization of viral vectors, LNPs and other nanoparticles
- VectorBuilder Ltd · 2027Listed as a 2027 exhibitor
- World Courier · 2026Booth 141 and a logistics talk at the 2026 congress
Speakers' companies (18)Catalent, Fondazione Telethon, Orchard Therapeutics and 15 more
- Catalent · 2026Talk on advanced therapy manufacturing on 17 March 2026
- Fondazione Telethon · 2027Ilaria Villa, Chief Executive Officer, on the 2027 agenda
- Orchard Therapeutics · 2027Bobby Gaspar, Chief Executive Officer, on the 2027 agenda
- Kiji Therapeutics · 2027Miguel Forte, CEO, on the 2027 agenda
- MeiraGTx · 2027Bastiaan Leewis, SVP MSAT, on the 2027 agenda
- Sofinnova Partners · 2027Matthieu Coutet, Partner, on the 2027 agenda
- Complement Therapeutics · 2027Rafiq Hasan, CEO, on the 2027 agenda
- Roche · 2027Florence Salmon, Global Head Regulatory Cell and Gene Therapies, on the 2027 agenda
- Resolution Therapeutics · 2027Lara Campana, SVP, Head of Research and Translational Science, on the 2027 agenda
- Forbion Capital Partners · 2027Sander Van Deventer, Operating Partner, on the 2027 agenda
- Autolus · 2027Chris Williams, Chief Business Officer, on the 2027 agenda
- Legend Biotech · 2027Sarah Snykers, Head of Site Strategy and Excellence, on the 2027 agenda
- TreeFrog Therapeutics · 2027Peter Andersen, Chief Research & Development Officer, on the 2027 agenda
- AstraZeneca · 2027Anna-Lina Cavallo, Director Discovery Cell and Gene Therapy integrated Bioanalysis, on the 2027 agenda
- Gilead Sciences · 2027Angela Borghouts - de Ruijter, Associate Director Market Access, on the 2027 agenda
- Vivet Therapeutics · 2027Jean-Philippe Combal, Co-Founder & CEO, on the 2027 agenda
- Advent Life Sciences · 2027Dominic Schmidt, General Partner, on the 2027 agenda
- Quell Therapeutics · 2027Rebecca Moore, Director, AD & QC, on the 2027 agenda
Attending (1)University of Sheffield Gene Therapy Innovation and Manufacturing Centre
Several companies confirmed their 2026 participation on their own pages, which shows the kind of firms that take part.
Exhibitors at Advanced Therapies UK
Exhibitors are mostly suppliers to cell and gene therapy developers, from CDMOs to cold chain couriers and analytics firms. Terrapinn's figures differ by page. The home page cites 200+ exhibitors and also 50 leading solution providers, so we don't quote a single count.
The 2027 sales catalog prices shell scheme space from £800 to £1,250 per square meter. Raw space costs £750 per square meter, or £500 for the largest 60 square meter plot. Each package adds a £395 admin fee, and full app access costs £250 extra.
Start-ups can book a pod for £500 as first-timers or £750 as returning companies. The start-up application page limits pods to firms under four years old with fewer than 25 staff. Our guide to what it costs to exhibit at a trade show helps put these prices in context.
Every exhibition package includes 1-to-1 networking through the app, a form of one-to-one meetings. Companies apply through Terrapinn's sponsor and exhibit enquiry form.
Sponsors and partners at Advanced Therapies UK
The 2027 sponsor list shows Lonza, Sartorius and Asimov as Platinum Sponsors and AGC Biologics as Gold Sponsor. Ten Silver Sponsors include Cytiva, Bio-Techne, Cryoport Systems, SK pharmteco and Cencora's World Courier. Aldevron, Andelyn Biosciences, BioLife Solutions and RoslinCT are Associate Sponsors.
The 2027 sales catalog ties tiers to spend. Title status starts at £50,000, Diamond at £40,000, Platinum at £30,000 and Gold at £27,000. A keynote plenary slot costs £42,000 and a hosted roundtable £10,000.
Other options include meeting pods from £5,000, app sponsorship at £20,000 and Wi-Fi branding at £12,000. Teams comparing tools for managing deals like these can see our list of event sponsorship software.
The event's tech
We couldn't identify a third-party registration platform on the event's website.
Advanced Therapies UK attendee list, exhibitor list and sponsor list
Exhibitor list
Published
Sponsor list
Published
Attendee list
Not published or sold
Terrapinn publishes one combined sponsor and exhibitor list with tiers, logos and short company profiles. It doesn't publish or sell an attendee list.
On other events, Terrapinn warns that it never sells or shares attendee data and calls list sellers a scam. Exhibitors meet buyers through the event app, which supports pre-booked 1-2-1 meetings. Compare event matchmaking software if you run meetings like these yourself.
For other ways to research who'll be there, see our guide on how to find who’s attending an event. Our roundup of event intelligence platforms covers tools that track exhibitors and sponsors across shows.
See who's attending Advanced Therapies UK
Organizers don't publish attendee lists. These event intelligence platforms show which companies and roles are likely to attend and help you book meetings. How to find who's attending
Speakers at Advanced Therapies UK 2027
The 2027 agenda opens with keynotes chaired by journalists from Bloomberg News and BBC News. Ilaria Villa, CEO of Fondazione Telethon, opens day one with a fireside chat on a not-for-profit gene therapy model.
- Ilaria VillaChief Executive Officer, Fondazione TelethonKeynote · Fireside Chat: Pioneering a new approach to advanced therapies · 2027
- Jacob GeorgeChief Medical and Scientific Officer, MHRAKeynote · Latest update from the MHRA on the regulatory framework for advanced therapies · 2027
- Bobby GasparChief Executive Officer, Orchard TherapeuticsKeynote · Fireside Chat: Navigating the landscape for gene therapies to achieve commercialisation · 2027
More speakers (22)Ashleigh Furlong, Catherine Burns, Andrew Joseph and 19 more
- Ashleigh FurlongHealth reporter, Bloomberg NewsModerator · Chair's Opening Remarks, day one · 2027
- Catherine BurnsBBC Health Correspondent, BBC NewsModerator · Chair's Opening Remarks, day two · 2027
- Andrew JosephEurope Correspondent, STATModerator · Fireside Chat: Navigating the landscape for gene therapies to achieve commercialisation · 2027
- Miguel ForteCEO, Kiji TherapeuticsModerator · Keynote Panel Discussion: From Discovery to Manufacturing, How is AI Transforming Cell & Gene Therapy Development? · 2027
- Bastiaan LeewisSVP MSAT, MeiraGTxPanelist · Keynote Panel Discussion: From Discovery to Manufacturing, How is AI Transforming Cell & Gene Therapy Development? · 2027
- Matthieu CoutetPartner, Sofinnova PartnersPanelist · Keynote Panel Discussion: From Discovery to Manufacturing, How is AI Transforming Cell & Gene Therapy Development? · 2027
- Rafiq HasanCEO, Complement TherapeuticsPanelist · Keynote Panel Discussion: From Discovery to Manufacturing, How is AI Transforming Cell & Gene Therapy Development? · 2027
- Florence SalmonGlobal Head Regulatory Cell and Gene Therapies, RochePanelist · Keynote Panel Discussion: From Discovery to Manufacturing, How is AI Transforming Cell & Gene Therapy Development? · 2027
- Lara CampanaSVP, Head of Research and Translational Science, Resolution TherapeuticsPanelist · Keynote Panel Discussion: From Discovery to Manufacturing, How is AI Transforming Cell & Gene Therapy Development? · 2027
- Sander Van DeventerOperating Partner, Forbion Capital PartnersPanelist · Panel Discussion: Where's the Money? Evolution and Future Outlook for Investment in Advanced Therapies · 2027
- Chris WilliamsChief Business Officer, AutolusPanelist · Panel Discussion: When's the right time to start planning for commercial launch? · 2027
- Lilian HookDirector of Cell, Apheresis and Gene Therapies, NHS Blood and TransplantInsight from the NHS on apheresis and donor supply · 2027
- Giulia LeonettiPolicy Officer, European CommissionLatest insight on EU policies for ATMP development · 2027
- Sarah SnykersHead of Site Strategy and Excellence, Legend BiotechPanelist · Panel Discussion: Considerations for Best Practice in Supply Chain and Logistics for Advanced Therapies · 2027
- Peter AndersenChief Research & Development Officer, TreeFrog TherapeuticsDelivering scalable manufacturing with quality in mind · 2027
- Anna-Lina CavalloDirector Discovery Cell and Gene Therapy integrated Bioanalysis, AstraZenecaModerator · Roundtable 8: Exploring the safety considerations of CRISPR technology and different approaches to epigenetic editing · 2027
- Angela Borghouts - de RuijterAssociate Director Market Access, Gilead SciencesModerator · Roundtable 12: Commercial ATMP initiatives vs point of care initiatives · 2027
- Jean-Philippe CombalCo-Founder & CEO, Vivet TherapeuticsModerator · Roundtable 7: Exploring board-room effectiveness in biotech · 2027
- Dominic SchmidtGeneral Partner, Advent Life SciencesModerator · Roundtable 7: Exploring board-room effectiveness in biotech · 2027
- Rebecca MooreDirector, AD & QC, Quell TherapeuticsModerator · Roundtable 2: Tech Transfer from AD to QC · 2027
- Anne RosserProfessor of Clinical Neurosciences, Cardiff UniversityModerator · Chair, Cell Therapy track, day two · 2027
- David MorrowScientific Lead for Advanced Therapies, EATRISModerator · Chair, Regulation track, day two · 2027
Jacob George, Chief Medical and Scientific Officer at the MHRA, gives a regulatory update on day two. Bobby Gaspar, CEO of Orchard Therapeutics, then joins a fireside chat on commercializing gene therapies.
A day one keynote panel asks how AI is changing cell and gene therapy development. It brings in speakers from MeiraGTx, Sofinnova Partners, Complement Therapeutics, Roche and Resolution Therapeutics. The speaker list named 241 people when we checked. Terrapinn's home page lists a contact for speaking enquiries.
Dates, venue and getting to Advanced Therapies UK
Advanced Therapies UK 2027 runs 9 to 10 March 2027 at ExCeL London on Royal Victoria Dock. The 2026 edition ran 17 to 18 March 2026 at ExCeL, as The Medicine Maker reported.
Terrapinn's venue page recommends the Elizabeth line and the DLR. Get off at Custom House for the west entrance or Prince Regent for the east entrance. ExCeL’s getting here page shows walking times between the two stations and entrances.
Drivers should use postcode E16 1FR for the car park, and parking can be pre-booked. Teams that also sell into bioprocessing can compare BioProcess International Europe 2027.
Tickets and registration for Advanced Therapies UK 2027
Tickets are sold through Terrapinn's registration page, with early prices ending 30 October 2026. The Standard Package with full app access costs £2,095 early, down from £3,495.
A Standard Package without the app upgrade costs £1,195 early. Pharma and biotech staff pay £995 early. Non-profits, clinicians, start-ups and academics pay £295 early. Prices exclude any taxes, and we checked them in October 2026.
Groups save 20% on three or more passes, 40% on five or more and 50% on ten or more. Group discounts don't apply to the government, NGO, non-profit and academic rate.
History of Advanced Therapies UK
Terrapinn says the congress has evolved over the past 20 years into a leading cell and gene event. It now runs each March at ExCeL London. It's a separate event from Advanced Therapies Week, which Phacilitate runs in the United States.
Resources for exhibitors, sponsors and attendees
These official Terrapinn pages cover registration, exhibiting, the program and the venue.
- Register for Advanced Therapies UK 2027To compare pass types and group rates.
- Sponsor and exhibit enquiry formTo ask about stands and sponsorship.
- 2027 sales catalogWith stand prices, sponsorship tiers and audience data.
- Download the prospectusThrough Terrapinn's request form.
- Sponsors and exhibitors listWith tiers and company profiles.
- 2027 agendaWith tracks, roundtables and session times.
- Speaker listWith every confirmed speaker.
- Start-up pod applicationWith eligibility rules.
- Poster applicationWith format and deadline.
- 2026 post-event reportThrough Terrapinn's request form.
- Venue and travel informationFor ExCeL London.